Results Evidence Progress
MORRISVILLE, N.C., Feb. 14, 2023 /PRNewswire/ -- Pyxus International, Inc. (OTC Pink: PYYX) ("Pyxus," the "Company," "we," or "our"), a global value-added agricultural company, today announced results for its fiscal quarter ended December 31, 2022.
Highlights (comparisons are to the relevant prior-year period):
- Sales and other operating revenues increased $226.7 million, or 52.9%, to $655.6 million for the three months ended December 31, 2022.
- Operating income increased $11.4 million to $41.6 million for the three months ended December 31, 2022.
- Net loss attributable to Pyxus International, Inc. improved by $27.8 million to $2.3 million for the three months ended December 31, 2022.
- Adjusted EBITDA* increased $18.3 million, or 42.4%, to $61.3 million for the three months ended December 31, 2022.
- Cash provided by operating activities increased $129.8 million to $176.1 million for the three months ended December 31, 2022.
|
|
|
|
|
|
|
|
|
|
|
|
*Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization ("Adjusted EBITDA") is not a measure of results under generally accepted accounting principles in the United States. Adjusted EBITDA expected for fiscal 2023 is calculated in a manner consistent with Adjusted EBITDA presented for historical periods as presented in the reconciliation tables included in this press release. Because of the forward-looking nature of the estimated range of Adjusted EBITDA, it is impractical to present a quantitative reconciliation of such measure to a comparable GAAP measure, and accordingly no such GAAP measure is being presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
Pieter Sikkel, Pyxus' President and CEO said, "We are excited to share our third quarter results. Our improved operating profit illustrates the Company's strong global performance in spite of a dynamic and complicated crop year that was exacerbated by La Nina and inflationary pressures. Our results evidence the progress the Company made year-over-year in several ways and would not have been possible without the dedication and contributions of our employees.
"We successfully utilized our global footprint to navigate the current tobacco supply shortage and meet our buying targets overall for fiscal 2023. Combined with continuing normalization of shipping schedules in North and South America and increased volume from Asia, the Company delivered an increase of more than 50% in sales and other operating revenues year-over-year. This increase and higher utilization of the Company's securitization programs resulted in cash flow from operations in the third quarter increasing by more than $100 million year-over-year. Some of these funds were strategically utilized to fully repay the outstanding indebtedness under the Company's ABL Credit Facility and provides the Company with increased financial flexibility as we approach the next buying cycle.
"We anticipate the third quarter to be our largest sales quarter of the fiscal year due to more normalized shipping schedules. Based on our expectations for continued improvement year-over-year, we have revised our expected fiscal 2023 sales to be between $1.85 billion and $2.00 billion and our adjusted EBITDA* expectations to be between $140 million and $155 million.
"Our strengthened performance also helps position the Company to progress against our environmental, social and governance ("ESG") targets. We recently released our Fiscal 2022 Sustainability Report, which provides stakeholders with a comprehensive understanding of how our ESG framework and business strategy are intertwined and reaffirms our commitment to transparent reporting as we execute against our measurable ESG goals.
"As we look beyond fiscal 2023, we continue to position the Company for long-term success. In February 2023, the Company successfully completed an exchange of its existing long-term debt with varying maturity dates for new long-term debt with maturity dates in 2027. Our new capital structure addresses approaching maturity dates, provides the Company with increased financial flexibility, and relief from certain restrictive covenants. The revised capital structure reflects the Company's progress over the past two fiscal years, and combined with continued normalization of shipping schedules, the potential for a larger crop cycle next year, and new strategic additions to our Board of Directors, we are excited about the Company's future and our ability to grow a better world."
Performance Summary for Three Months Ended December 31, 2022
Sales and other operating revenues were $428.9 million for the three months ended December 31, 2021 and $655.6 million for the three months ended December 31, 2022, an increase of $226.7 million, or 52.9%. This increase was primarily due to a 21.9% increase in leaf volume and a 29.8% increase in average price per kilo. The increase in leaf volume was driven by increased volume from Asia, more normalized timing of shipments from South America from the current crop, and the timing of shipments from North America that were delayed from the three months ended September 30, 2022 into the three months ended December 31, 2022. The increase in average price per kilo was mainly due to higher tobacco prices.
Cost of goods and services sold were $363.7 million for the three months ended December 31, 2021 and $567.8 million for the three months ended December 31, 2022, an increase of $204.1 million, or 56.1%. This increase was mainly due to the increase in sales and other operating revenues. Average cost per kilo increased primarily due to higher tobacco prices.
Gross profit was $65.2 million for the three months ended December 31, 2021 and $87.8 million for the three months ended December 31, 2022, an increase of $22.6 million, or 34.7%. This increase was mainly due to the increase in sales and other operating revenues. Gross profit as a percent of sales went from 15.2% for the three months ended December 31, 2021 to 13.4% for the three months ended December 31, 2022. This decrease was primarily due to the impact of short-crops in certain markets in Africa and product mix in North America.
Average gross profit per kilo for product revenue was $0.55 for the three months ended December 31, 2021 and $0.64 for the three months ended December 31, 2022, an increase of $0.09 per kilo or 16.4%. This increase was primarily due to customer mix in North and South America and product mix in Africa and Asia.
Other expense, net was $0.2 million of income for the three months ended December 31, 2021 and $9.0 million of expense for the three months ended December 31, 2022, an increase of $9.2 million. This increase was primarily due to higher utilization of securitization facilities.
Operating income was $30.2 million for the three months ended December 31, 2021 and $41.6 million for the three months ended December 31, 2022, an increase of $11.4 million, or 37.7%. This increase was mainly due to higher leaf sales and other operating revenues from increased volume and average price per kilo and was partially offset by higher other expense, net, which was primarily due to higher utilization of securitization facilities.
Income tax expense was $31.8 million for the three months ended December 31, 2021 and $17.9 million for the three months ended December 31, 2022, a decrease of $13.9 million, or 43.7%. The decrease was driven by the Company utilizing a different method for estimating tax expense for the period ended December 31, 2022. Using the discrete method for the period ended December 31, 2022, the Company determined current and deferred income tax expense as if the nine-month interim period of the current fiscal year were an annual period, which resulted in the recognition of the fiscal 2023 year-to-date expense in the quarter.
Liquidity and Capital Resources
The Company's liquidity requirements are affected by various factors including crop seasonality, foreign currency and interest rates, green tobacco prices, customer mix, crop size and quality. In line with our strategy, the increase in green tobacco prices and processing costs in South America required additional working capital that was primarily sourced from increased seasonal lines and more efficient cash management. The following table summarizes the Company's cash and available credit:
(in millions)
| December 31, 2022
| December 31, 2021
|
Cash and cash equivalents
| $ 216.4
| $ 146.1
|
ABL Credit Facility
| 100.0
| 22.5
|
Foreign seasonal lines of credit
| 218.9
| 235.2
|
Other long-term debt
| 0.1
| 0.6
|
Letters of credit
| 4.1
| 3.4
|
Total
| $ 539.5
| $ 407.8
|
Financial Results Investor Call
The Company will hold a conference call to report financial results for the period ended December 31, 2022, on February 14, 2023 at 5:00 P.M. ET. The dial in number for the call is (646) 960-0369 or (888) 350-3452 and the conference ID is 2624736. Those seeking to listen to the call may access a live broadcast on the Pyxus International website. Please visit www.pyxus.com 15 minutes in advance to register.
For those who are unable to listen to the live event, a replay will be available for five days by dialing (647) 362-9199 or (800) 770-2030 and entering the access code 2624736. Any replay, rebroadcast, transcript, or other reproduction of this conference call, other than the replay accessible by calling the number above, has not been authorized by Pyxus International and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.
Cautionary Statement Regarding Forward-Looking Statements
Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in our Annual Report on Form 10-K for the year ended March 31, 2022, our most recent Quarterly Report on Form 10-Q, and in our other filings with the Securities and Exchange Commission. These risks and uncertainties include: our reliance on a small number of significant customers; continued vertical integration by our customers; global shifts in sourcing customer requirements; shifts in the global supply and demand position for tobacco products; variation in our financial results due to growing conditions, customer indications and other factors; loss of confidence in us by our customers, farmers and other suppliers; migration of suppliers who have historically grown tobacco and from whom we have purchased tobacco toward growing other crops; risks related to our advancement of inputs to tobacco suppliers to be settled upon the suppliers delivering us unprocessed tobacco at the end of the growing season; risks that the tobacco we purchase directly from suppliers will not meet our customers' quality and quantity requirements; weather and other environmental conditions that can affect the marketability of our inventory; international business risks, including unsettled political conditions, uncertainty in the enforcement of legal obligations, including the collection of accounts receivable, fraud risks, expropriation, import and export restrictions, exchange controls, inflationary economies, currency risks and risks related to the restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries; many of our operations are located in jurisdictions that pose a high risk of potential violations of the Foreign Corrupt Practices Act; impacts of international sanctions on our ability to sell or source tobacco in certain regions; exposure to foreign tax regimes in which the rules are not clear, are not consistently applied and are subject to sudden change; fluctuations in foreign currency exchange and interest rates; competition with the other primary global independent leaf tobacco merchant and independent leaf merchants; disruption, failure or security breaches of our information technology systems; continued high inflation; we have identified material weaknesses related to our internal controls in certain prior years, and there can be no assurance that material weaknesses will not be identified in the future; regulations regarding environmental matters; risks related to our capital structure, including risks related to our significant debt and our ability to continue to finance our non-U.S. local operations with uncommitted short-term operating credit lines at the local level; our ability to continue to access capital markets to obtain long-term and short-term financing; potential failure of foreign banks in which our subsidiaries maintain deposits or the failure by such banks to transfer funds or honor withdrawals; the risk that, because our ability to generate cash depends on many factors beyond our control, we may be unable to generate the significant amount of cash required to service our indebtedness; our ability to refinance our current credit facilities at the same availability or at similar interest rates; failure to achieve our stated goals, which may adversely affect our liquidity; developments with respect to our liquidity needs and sources of liquidity; the volatility and disruption of global credit markets; failure by counterparties to derivative transactions to perform their obligations; increasing scrutiny and changing expectations from governments, as well as other stakeholders such as investors and customers, with respect to our environmental, social and governance policies, including sustainability policies; inherent risk of exposure to product liability claims, regulatory action and litigation facing our e-liquids business if its products are alleged to have caused significant loss, injury, or death; certain shareholders have the ability to exercise controlling influence on various corporate matters; reductions in demand for consumer tobacco products; risks and uncertainties related to the COVID-19 pandemic and its related shipping constraints, labor shortages and supply-chain impacts; legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for our services and increase regulatory burdens on us or our customers; government actions that significantly affect the sourcing of tobacco, including governmental actions to identify and assess crop diversification initiatives and alternatives to leaf tobacco growing in countries whose economies depend upon tobacco production; governmental investigations into, and litigation concerning, leaf tobacco industry buying and other payment practices; and impact of potential regulations to prohibit the sale of cigarettes in the United States other than low-nicotine cigarettes.
A further list and description of these risks, uncertainties, and other factors can be found in Part I, Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended March 31, 2022, its Quarterly Report on Form 10-Q for the period ended December 31, 2022, and in its other filings with the Securities and Exchange Commission. The Company does not undertake to update any forward-looking statements that it may make from time to time except to the extent required by law.
Non-GAAP Financial Information
This press release contains financial measures that have not been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). They include EBITDA, Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, and Net Debt. Tables showing the reconciliation of historical non-GAAP financial measures are attached to the release. The range of Adjusted EBITDA anticipated for fiscal year ending March 31, 2023 is calculated in a manner consistent with the presentation of Adjusted EBITDA in the attached tables. Because of the forward-looking nature of the estimated range of Adjusted EBITDA, it is impractical to present a quantitative reconciliation of such measure to a comparable GAAP measure, and accordingly no such GAAP measure is being presented.
About Pyxus International, Inc.
Pyxus International, Inc. is a global agricultural company with 150 years of experience delivering value-added products and services to businesses and customers. Driven by a united purpose—to transform people's lives, so that together we can grow a better world—Pyxus International, its subsidiaries and affiliates, are trusted providers of responsibly sourced, independently verified, sustainable and traceable products and ingredients. For more information, visit www.pyxus.com.
Condensed Consolidated Statements of Operations
|
|
|
|
| Three Months Ended
| Nine Months Ended
|
| December 31,
| December 31,
|
(in thousands, except per share data)
| 2022
| 2021
| 2022
| 2021
|
Sales and other operating revenues
| $ 655,553
| $ 428,942
| $ 1,507,736
| $ 1,156,433
|
Cost of goods and services sold
| 567,752
| 363,716
| 1,311,861
| 997,033
|
Gross profit
| 87,801
| 65,226
| 195,875
| 159,400
|
Selling, general, and administrative expenses
| 37,119
| 34,235
| 106,694
| 106,005
|
Other expense (income), net
| 9,040
| (163)
| 9,106
| 1,491
|
Restructuring and asset impairment charges
| 35
| 560
| 4,380
| 7,652
|
Goodwill impairment
| —
| 372
| —
| 372
|
Operating income
| 41,607
| 30,222
| 75,695
| 43,880
|
Loss on deconsolidation/disposition of subsidiaries
| —
| 7,069
| 648
| 9,525
|
Loss on pension settlement
| —
| —
| 2,588
| —
|
Interest expense, net
| 31,361
| 27,503
| 85,649
| 82,820
|
Income (loss) before income taxes and other items
| 10,246
| (4,350)
| (13,190)
| (48,465)
|
Income tax expense
| 17,887
| 31,809
| 15,810
| 9,242
|
Income from unconsolidated affiliates
| 5,404
| 6,102
| 10,708
| 5,999
|
Net loss
| (2,237)
| (30,057)
| (18,292)
| (51,708)
|
Net income (loss) income attributable to noncontrolling interests
| 96
| 43
| 241
| (419)
|
Net loss attributable to Pyxus International, Inc.
| $ (2,333)
| $ (30,100)
| $ (18,533)
| $ (51,289)
|
|
|
|
|
|
Loss per share:
|
|
|
|
|
Basic and diluted
| $ (0.09)
| $ (1.20)
| $ (0.74)
| $ (2.05)
|
|
|
|
|
|
Weighted average number of shares outstanding:
|
|
|
|
|
Basic and diluted
| 25,000
| 25,000
| 25,000
| 25,000
|
Condensed Consolidated Balance Sheets
|
|
(in thousands)
| December 31, 2022
| December 31, 2021
|
Assets
|
|
|
Current assets
|
|
|
Cash, cash equivalents, and restricted cash
| $ 218,385
| $ 149,854
|
Trade and other receivables, net
| 222,327
| 206,722
|
Inventories and advances to tobacco suppliers
| 776,252
| 802,044
|
Recoverable income taxes
| 7,053
| 5,320
|
Prepaid expenses and other current assets
| 47,143
| 47,275
|
Total current assets
| 1,271,160
| 1,211,215
|
Restricted cash
| —
| 389
|
Investments in unconsolidated affiliates
| 94,099
| 92,459
|
Goodwill and other intangible assets, net
| 39,732
| 78,144
|
Long-term tax assets
| 13,182
| 9,186
|
Other noncurrent assets
| 43,086
| 36,085
|
Right-of-use assets
| 32,842
| 35,417
|
Property, plant, and equipment, net
| 136,556
| 137,802
|
Total assets
| $ 1,630,657
| $ 1,600,697
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
Current liabilities
|
|
|
Notes payable to banks
| $ 492,326
| $ 384,230
|
Accounts payable
| 135,092
| 90,025
|
Advances from customers
| 30,826
| 63,176
|
Accrued expenses and other current liabilities
| 95,312
| 79,584
|
Income taxes payable
| 6,665
| 6,909
|
Operating leases payable
| 9,097
| 7,624
|
Current portion of long-term debt
| 97,282
| 107,687
|
Total current liabilities
| 866,600
| 739,235
|
Long-term debt
| 496,636
| 541,096
|
Long-term leases
| 23,663
| 27,148
|
Long-term tax liabilities
| 31,022
| 31,318
|
Pension, postretirement, and other long-term liabilities
| 56,990
| 64,030
|
Total liabilities
| 1,474,911
| 1,402,827
|
Commitments and contingencies
|
|
|
Stockholders' equity
|
|
|
Common stock
| 390,290
| 390,290
|
Retained deficit
| (237,346)
| (187,983)
|
Accumulated other comprehensive loss
| (477)
| (10,053)
|
Total stockholders' equity of Pyxus International, Inc.
| 152,467
| 192,254
|
Noncontrolling interests
| 3,279
| 5,616
|
Total stockholders' equity
| 155,746
| 197,870
|
Total liabilities and stockholders' equity
| $ 1,630,657
| $ 1,600,697
|
|
|
|
|
|
|
Segment Results
|
|
Three Months Ended December 31, 2022 and 2021
|
| Three Months Ended December 31,
|
|
|
| Change
|
(in thousands, except per kilo amounts)
| 2022
| 2021
| $
| %
|
Leaf:
|
|
|
|
|
Sales and other operating revenues
| $ 625,129
| $ 394,823
| 230,306
| 58.3
|
Tobacco costs
| 510,194
| 313,613
| 196,581
| 62.7
|
Transportation, storage, and other period costs
| 32,832
| 23,206
| 9,626
| 41.5
|
Total cost of goods sold
| 543,026
| 336,819
| 206,207
| 61.2
|
Product revenue gross profit
| 82,103
| 58,004
| 24,099
| 41.5
|
Product revenue gross profit as a percent of sales
| 13.1 %
| 14.7 %
|
|
|
|
|
|
|
|
Kilos sold
| 129,449
| 106,179
| 23,270
| 21.9
|
Average price per kilo
| $ 4.83
| $ 3.72
| 1.11
| 29.8
|
Average cost per kilo
| 4.19
| 3.17
| 1.02
| 32.2
|
Average gross profit per kilo
| 0.64
| 0.55
| 0.09
| 16.4
|
|
|
|
|
|
Processing and other revenues
| $ 27,128
| $ 31,301
| (4,173)
| (13.3)
|
Processing and other revenues costs of services sold
| 20,526
| 22,265
| (1,739)
| (7.8)
|
Processing and other gross profit
| 6,602
| 9,036
| (2,434)
| (26.9)
|
Processing and other gross profit as a percent of sales
| 24.3 %
| 28.9 %
|
|
|
|
|
|
|
|
All Other:
|
|
|
|
|
Sales and other operating revenues
| $ 3,296
| $ 2,818
| 478
| 17.0
|
Cost of goods and services sold
| 4,200
| 4,632
| (432)
| (9.3)
|
Gross loss
| (904)
| (1,814)
| 910
| 50.2
|
Gross loss as a percent of sales
| (27.4) %
| (64.4) %
|
|
|
|
Nine Months Ended December 31, 2022 and 2021
|
| Nine Months Ended December 31,
|
|
|
| Change
|
(in thousands, except per kilo amounts)
| 2022
| 2021
| $
| %
|
Leaf:
|
|
|
|
|
Sales and other operating revenues
| $ 1,423,612
| $ 1,064,280
| 359,332
| 33.8
|
Tobacco costs
| 1,164,838
| 858,293
| 306,545
| 35.7
|
Transportation, storage, and other period costs
| 77,823
| 63,467
| 14,356
| 22.6
|
Total cost of goods sold
| 1,242,661
| 921,760
| 320,901
| 34.8
|
Product revenue gross profit
| 180,951
| 142,520
| 38,431
| 27.0
|
Product revenue gross profit as a percent of sales
| 12.7 %
| 13.4 %
|
|
|
|
|
|
|
|
Kilos sold
| 302,915
| 261,585
| 41,330
| 15.8
|
Average price per kilo
| $ 4.70
| $ 4.07
| 0.63
| 15.5
|
Average cost per kilo
| 4.10
| 3.52
| 0.58
| 16.5
|
Average gross profit per kilo
| 0.60
| 0.55
| 0.05
| 9.1
|
|
|
|
|
|
Processing and other revenues
| $ 75,212
| $ 82,657
| (7,445)
| (9.0)
|
Processing and other revenues costs of services sold
| 56,073
| 59,223
| (3,150)
| (5.3)
|
Processing and other gross profit
| 19,139
| 23,434
| (4,295)
| (18.3)
|
Processing and other gross profit as a percent of sales
| 25.4 %
| 28.4 %
|
|
|
|
|
|
|
|
All Other:
|
|
|
|
|
Sales and other operating revenues
| $ 8,912
| $ 9,496
| (584)
| (6.1)
|
Cost of goods and services sold
| 13,127
| 16,050
| (2,923)
| (18.2)
|
Gross loss
| (4,215)
| (6,554)
| 2,339
| 35.7
|
Gross loss as a percent of sales
| (47.3) %
| (69.0) %
|
|
|
Reconciliation of Certain Non-GAAP Financial Measures(1) (Unaudited)
|
|
| Three Months Ended
| Nine Months Ended
| Fiscal Year Ended
| Last Twelve Months(9)
|
(in thousands)
| December 31,
2022
| December 31,
2021
| December 31,
2022
| December 31,
2021
| March 31,
2022
| March 31,
2021*
| December 31,
2022
| December 31,
2021
|
Net loss attributable to Pyxus International, Inc.
| $ (2,333)
| $ (30,100)
| $ (18,533)
| $ (51,289)
| $ (82,119)
| $ (117,649)
| (49,363)
| $ (174,497)
|
Plus: Interest expense
| 32,053
| 27,818
| 89,805
| 84,376
| 111,043
| 103,340
| 116,472
| 107,999
|
Plus: Income tax expense
| 17,887
| 31,809
| 15,810
| 9,242
| 12,640
| 13,507
| 19,208
| 28,548
|
Plus: Depreciation and amortization expense
| 4,394
| 3,814
| 14,678
| 11,984
| 16,676
| 28,419
| 19,370
| 10,522
|
EBITDA(1)
| 52,001
| 33,341
| 101,760
| 54,313
| 58,240
| 27,617
| 105,687
| (27,428)
|
Plus: Reserves for doubtful customer receivables
| (139)
| 377
| (129)
| 3,268
| 4,404
| 4,663
| 1,007
| 7,234
|
Plus: Other expense (income), net
| 9,040
| (163)
| 9,106
| 1,491
| 3,349
| 10,154
| 10,964
| 13,842
|
Plus: Restructuring and asset impairment charges(2)
| 245
| 560
| 5,855
| 7,652
| 8,031
| 12,383
| 6,234
| 10,478
|
Plus: Goodwill impairment
| —
| 372
| —
| 372
| 32,186
| 1,082
| 31,814
| 1,454
|
Plus: Reorganization items(3)
| —
| —
| —
| —
| —
| (105,984)
| —
| —
|
Plus: Debt restructuring(4)
| 63
| 1,006
| 713
| 3,286
| 3,550
| 23,590
| 977
| 5,062
|
Plus: Pension retirement expense(5)
| —
| —
| 2,724
| —
| —
| —
| 2,724
| —
|
Plus: Development of and exit from non-leaf-
tobacco businesses(6)
| 18
| 7,150
| 697
| 12,306
| 13,589
| 113,954
| 1,980
| 95,466
|
Plus: Other adjustments(7)
| 41
| 368
| 695
| 942
| 3,347
| 6,065
| 3,100
| 1,382
|
Adjusted EBITDA(1)
| $ 61,269
| $ 43,011
| $ 121,421
| $ 83,630
| $ 126,696
| $ 93,524
| $ 164,487
| $ 107,490
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
|
| $ 1,066,945
| $ 925,531
| $ 1,086,244
| $ 1,033,013
|
Less: Cash and cash equivalents
|
|
|
|
| 198,777
| 92,705
| 216,449
| 146,083
|
Net debt(1)
|
|
|
|
| $ 868,168
| $ 832,826
| $ 869,795
| $ 886,930
|
Net debt /Adjusted EBITDA(1)
|
|
|
|
| 6.85x
| 8.90x
| 5.29x
| 8.25x
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA(1)
|
|
|
|
| $ 126,696
| $ 93,524
| $ 164,487
| $ 107,490
|
Interest expense
|
|
|
|
| 111,043
| 103,340
| 116,472
| 107,999
|
Interest coverage
|
|
|
|
| 1.14x
| 0.91x
| 1.41x
| 1.00x
|
|
|
|
|
|
|
|
|
|
Net cash provided (used) by operating activities
| 176,069
| 46,313
| (110,599)
| (184,831)
| (198,765)
| (226,536)
| (124,533)
| (203,764)
|
Capital expenditures
| (4,505)
| (3,633)
| (9,931)
| (12,201)
| (14,827)
| (24,385)
| (12,557)
| (17,272)
|
Collections on beneficial interest on securitized
trade receivables(8)
| 46,429
| 72,577
| 122,638
| 155,226
| 189,440
| 168,390
| 156,852
| 199,726
|
Free Cash Flow(1)
| $ 217,993
| $ 115,257
| $ 2,108
| $ (41,806)
| $ (24,152)
| $ (82,531)
| $ 19,762
| $ (21,310)
|
Plus: Interest expense
| 32,053
| 27,818
| 89,805
| 84,376
| 111,043
| 103,340
| 116,472
| 107,999
|
Plus: Income tax expense
| 17,887
| 31,809
| 15,810
| 9,242
| 12,640
| 13,507
| 19,208
| 28,548
|
Adjusted Free Cash Flow(1)
| $ 267,933
| $ 174,884
| $ 107,723
| $ 51,812
| $ 99,531
| $ 34,316
| $ 155,442
| $ 115,237
|
*Combined (Non-GAAP) for the five months ended August 31, 2020 (Predecessor period) and the seven months ended March 31, 2021 (Successor period), which periods were presented separately
in light of the resolution of the Chapter 11 cases (the "Chapter 11 Cases") of the Company's predecessor and certain of its subsidiaries commenced in June 2020. A presentation of these combined
results for the twelve-month period ended March 31, 2021 is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed with the Securities and Exchange
Commission.
|
|
|
1.
| Earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"), Free Cash Flow, Adjusted Free Cash Flow, and Net Debt are not measures of results of operations, cash flows from operations, or indebtedness under generally accepted accounting principles in the United States ("U.S. GAAP") and should not be considered as an alternative to other U.S. GAAP measurements. We have presented EBITDA, Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, and Net Debt to adjust for the items identified above because we believe that it would be helpful to the readers of our financial information to understand the impact of these items on our reported amounts. This presentation enables readers to better compare our results to similar companies that may not incur the impact of various items identified above. Management acknowledges that there are many items that impact a company's reported results or operating cash flows and these lists are not intended to present all items that may have impacted these items. EBITDA, Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, Net Debt, and any ratios calculated based on these measures are not necessarily comparable to similarly-titled measures used by other companies or appearing in our debt obligations or agreements. EBITDA, Adjusted EBITDA, Free Cash Flow, and Adjusted Free Cash Flow as presented may not equal column or row totals due to rounding.
|
|
|
2.
| Amounts incurred during the three and nine months ended December 31, 2022 included employee separation and asset impairment charges primarily related to the restructuring of certain non-leaf agriculture operations and related inventory write-offs classified within cost of goods and services sold in the Company's condensed consolidated statements of operations.
|
|
|
3.
| Represents expenditures, gains, and losses that were realized or incurred subsequent to the commencement of the Chapter 11 Cases and as a direct result of the Chapter 11 Cases, which are reported as reorganization items in the condensed consolidated statements of operations, and are primarily composed of write-off of unamortized debt issuance costs and discount, fresh start reporting adjustments, legal, valuation, and consulting professional fees pertaining to the Chapter 11 Cases, United States trustee fees, and debtor-in-possession financing fees.
|
|
|
4.
| Legal and professional fees incurred in connection with the Chapter 11 Cases, including in preparation for the commencement of the Chapter 11 Cases, not otherwise included in "Reorganization items" and, for the three, nine, and twelve months ended December 31, 2021 and fiscal year ended March 31, 2022, also includes consulting fees incurred in connection with the implementation of process improvements required in connection with the Company's delayed-draw term loan credit facility established in the current fiscal year. Also includes legal and professional fees incurred during the three and nine months ended December 31, 2022, associated with the amendment and extension of the delayed-draw term loan.
|
|
|
5.
| During the nine months ended December 31, 2022, the Company settled benefits with vested participants in the U.S. defined benefit pension plan ("U.S. Pension Plan") that elected a lump sum payout and made a cash contribution to fully fund the U.S. Pension Plan's liabilities in preparation to purchase a group annuity contract to administer future payments to the remaining U.S. Pension Plan participants. This adjustment includes pension settlement charges incurred during the nine months ended December 31, 2022 and were classified as loss on pension settlement expense and selling, general, and administration expenses in the Company's condensed consolidated statements of operations.
|
|
|
6.
| Includes the aggregate amount of certain items related to the Company's development of and subsequent exits from its non-leaf-tobacco businesses (that is, the production and sale of legal cannabis in Canada, the production and sale of industrial hemp products, including CBD extracted from industrial hemp, and the production and sale of tobacco e-liquids) to the extent such items are included in the Company's consolidated results of operations, which includes all items separately reported for such businesses in the presentation by the Company of its adjusted EBITDA in prior periods. Such items include, to the extent reflected in consolidated results, the adjusted EBITDA of the Canadian cannabis and industrial hemp operations otherwise calculated on the same basis as Adjusted EBITDA is presented in this table, loss incurred on the deconsolidation or disposition of certain of these non leaf-tobacco businesses, as applicable, and write-offs of inventory and equipment related to certain of these businesses.
|
|
|
7.
| Includes the following items: (i) the addition of unrecovered amounts expensed directly to cost of goods and services sold in the income statement for abnormal yield adjustments or unrecovered amounts from prior crops (normal yield adjustments are capitalized into the cost of the current crop and are expensed as cost of goods and services sold as that crop is sold), (ii) the addition of non-cash employee stock-based compensation, (iii) the addition of amortization of basis difference related to a former Brazilian subsidiary that is now deconsolidated following the completion of a joint venture in March 2014, (iv) the subtraction of the Adjusted EBITDA of the Company's former green leaf sourcing operation in Kenya, which is calculated on the same basis as Adjusted EBITDA presented in this table (in fiscal year 2016 the Company decided to exit green leaf sourcing in the Kenyan market as part of our restructuring program), (v) debt retirement expense, and (vi) income (included in Other (expense) income, net) from cash received in the period presented from the sale of Brazilian intrastate trade tax credits that had been generated by intrastate purchases of tobacco primarily in prior crop years. The Brazilian states of Rio Grande do Sul and Santa Catarina permit the sale or transfer of excess credits to third parties subject to approval by the related tax authorities. The Company has long-term agreements with these Brazilian state governments regarding the amounts and timing of credits that can be sold. Intrastate trade tax credits that are not able to be sold under existing agreements are capitalized into the cost of the current crop and are expensed as cost of goods and services sold as that crop is sold.
|
|
|
8.
| Represents cash receipts from the beneficial interest on sold receivables under the Company's accounts receivable securitization programs and were classified as investing activities in the Company's condensed consolidated statements of cash flows.
|
|
|
9.
| Items for the twelve months ended December 31, 2022 are derived by adding the items for the nine months ended December 31, 2022 as presented in the table and the fiscal year ended March 31, 2022 and subtracting the items for the nine months ended December 31, 2021. Items for the twelve months ended December 31, 2021 are derived by adding the items for the nine months ended December 31, 2021 and the combined fiscal year ended March 31, 2021 and subtracting the items for the nine months ended December 31, 2020.
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/pyxus-international-inc-reports-fiscal-year-2023-third-quarter-results-301746870.html
SOURCE Pyxus International, Inc.
